Itóh S, Landström M, Hermansson A, Itoh F, Heldin C H, Heldin N E, ten Dijke P
Ludwig Institute for Cancer Research, Biomedical Center Box 595, S-751 24 Uppsala, Sweden.
J Biol Chem. 1998 Oct 30;273(44):29195-201. doi: 10.1074/jbc.273.44.29195.
Transforming growth factor beta (TGF-beta) signals from membrane to nucleus through serine/threonine kinase receptors and their downstream effector molecules, termed Smad proteins. Recently, Smad6 and Smad7 were identified, which antagonize TGF-beta family signaling by preventing the activation of signal-transducing Smad complexes. Here we report that Smad7, but not Smad6, inhibits TGF-beta1-induced growth inhibition and the expression of immediate early response genes, including Smad7. Interestingly, in the absence of ligand, Smad7 was found to be predominantly localized in the nucleus, whereas Smad7 accumulated in the cytoplasm upon TGF-beta receptor activation. The latter is in accordance with the physical association of Smad7 with the ligand-activated TGF-beta receptor complex in the cell membrane. Whereas the ectopically expressed C-terminal domain of Smad7 was also exported from the nucleus to the cytoplasm upon TGF-beta challenge, a Smad7 mutant with a small deletion at the C terminus or only the N-terminal domain of Smad7 was localized mainly in the cytoplasm in the absence or presence of ligand. This suggests that an intact Mad homology 2 domain is important for nuclear localization of Smad7. The nuclear localization of Smad7 suggests a functional role distinct from its antagonistic effect in receptor-mediated Smad activation.
转化生长因子β(TGF-β)通过丝氨酸/苏氨酸激酶受体及其下游效应分子(称为Smad蛋白)将信号从细胞膜传递至细胞核。最近,人们鉴定出了Smad6和Smad7,它们通过阻止信号转导Smad复合物的激活来拮抗TGF-β家族信号。在此我们报告,Smad7而非Smad6可抑制TGF-β1诱导的生长抑制以及包括Smad7在内的即刻早期反应基因的表达。有趣的是,在没有配体的情况下,发现Smad7主要定位于细胞核中,而在TGF-β受体激活后,Smad7则在细胞质中积累。后者与Smad7在细胞膜中与配体激活的TGF-β受体复合物的物理结合相一致。尽管在TGF-β刺激后,异位表达的Smad7的C末端结构域也从细胞核输出至细胞质,但在C末端有小缺失的Smad7突变体或仅Smad7的N末端结构域在有无配体的情况下都主要定位于细胞质中。这表明完整的Mad同源2结构域对于Smad7的核定位很重要。Smad7的核定位表明其具有与其在受体介导的Smad激活中的拮抗作用不同的功能。